Ausgabe 12/2022
Inhalt (20 Artikel)
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
Shuai Shao, Gang Wang
Artificial Intelligence in Dermatology: Challenges and Perspectives
Konstantinos Liopyris, Stamatios Gregoriou, Julia Dias, Alexandros J. Stratigos
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
Ahmad N. Fasseeh, Baher Elezbawy, Nada Korra, Mohamed Tannira, Hala Dalle, Sandrine Aderian, Sherif Abaza, Zoltán Kaló
New Developing Treatments for Molluscum Contagiosum
Francesco Lacarrubba, Giuseppe Micali, Andrea Calogero Trecarichi, Enrica Quattrocchi, Giuseppe Monfrecola, Anna Elisa Verzì
The Impact of Global Health Disparities on Atopic Dermatitis in Displaced Populations: Narrowing the Health Equity Gap for Patients with Skin of Color
Sami Jelousi, Divya Sharma, Andrew Alexis, Jenny E. Murase
Current and Emerging Therapies in Pediatric Atopic Dermatitis
Hadley Johnson, JiaDe Yu
Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics
Nikita S. Wong, Taylor M. Adlam, Geoffrey A. Potts, Mehdi Farshchian
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
Anastasia Drakos, Ronald Vender
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
Jonathan I. Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A. Papp, Haixin Zhang, Ana B. Rossi, Noah A. Levit
Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data
Irina Pivneva, Maria-Magdalena Balp, Yvonne Geissbühler, Thomas Severin, Serge Smeets, James Signorovitch, Jimmy Royer, Yawen Liang, Tom Cornwall, Jutong Pan, Andrii Danyliv, Sarah Jane McKenna, Alexander M. Marsland, Weily Soong
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
Norito Katoh, Yasushi Takita, Yoshitaka Isaka, Atsushi Nishikawa, Hitoe Torisu-Itakura, Hidehisa Saeki
Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
Christiane Querfeld, Winnie W. Nelson, Deval Gor, Chris L. Pashos, Quan V. Doan, Marco Turini, James T. Angello, Larisa J. Geskin
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
Benjamin Lockshin, Ryan W. Harrison, Robert R. McLean, Margaux M. Crabtree, Bruce W. Konicek, Baojin Zhu, William N. Malatestinic, Bilal Atiya, Mwangi J. Murage, Russel T. Burge
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS)
Jonathan I. Silverberg, Eric L. Simpson, Brian M. Calimlim, Leighann Litcher-Kelly, Xiaoran Li, Xiaowu Sun, Yael A. Leshem
Multidisciplinary Rheuma–Derma Clinics: 5 Years of Experience at the San Marco Hospital in Catania
Rosario Foti, Giorgia Giuffrida, Alice Ramondetta, Giorgio Amato, Elisa Visalli, Riccardo Foti, Francesco De Lucia, Ylenia Dal Bosco, Rocco De Pasquale
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
Amy S. Paller, Gil Yosipovitch, Stephan Weidinger, Dana DiBenedetti, Diane Whalley, Abhijit Gadkari, Isabelle Guillemin, Haixin Zhang, Laurent Eckert, Jingdong Chao, Ashish Bansal, Chien-Chia Chuang, Dimittri Delevry
Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
Grażyna Kamińska-Winciorek, Katarzyna Galwas, Magdalena Suchorzepka, Barbara Ziółkowska, Maria Turska-d’Amico, Wiesław Bal, Claudio Conforti, Ludovica Toffoli, Bożena Cybulska-Stopa, Iris Zalaudek
Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
Dan Pettitt, Michael Plotnick, Joshua Gagne
A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
April W. Armstrong, Ahmed M. Soliman, Keith A. Betts, Yan Wang, Yawen Gao, Vassilis Stakias, Luis Puig
Correction to: Leg Ulcer Therapy by Local Injection of Autologous Growth Factors: Results of a Pilot Study
Petr Šíma, Valér Džupa, Adam Whitley, Spyridon Gkalpakiotis